Bequest establishes Barber Center for Multiscale Systems Biology Today@Wayne
Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to Today@Wayne.
The synthetic biology industry is increasingly focused on the challenges of scaling DNA manufacturing to meet the demands of next-generation therapeutic development. As genetic medicines move toward commercialization, the industry requires more efficient and scalable methods for synthesizing high-fidelity DNA sequences. This shift is critical for ensuring that advanced treatments, such as cell and gene therapies, can be produced reliably and cost-effectively for global patient populations.
June 26, 2026The U.S. National Science Foundation (NSF) and the National Institute of Standards and Technology (NIST), with significant backing from Schmidt Sciences, have announced five Scholars-in-Residence awards to establish critical standards and metrics for the bioeconomy. This initiative aims to accelerate engineering biology research by providing researchers with direct access to NIST’s advanced laboratory facilities and automation expertise. By focusing on the development of shareable standards for engineering microorganisms and cell-free systems, the program seeks to enhance scientific predictability and ensure the U.S. remains globally competitive in the synthetic biology sector.
June 25, 2026Professor Jason Chin has been awarded the 2026 Heinrich Wieland Prize for his pioneering work in expanding the genetic code, a breakthrough that allows for the systematic rewriting of biological rules. This recognition highlights the transition of synthetic biology from academic theory to an industrial-scale platform for therapeutic innovation through his company, Constructive Bio. By enabling the incorporation of non-natural amino acids into proteins, the technology provides a new blueprint for developing resilient medicines with enhanced properties and more sustainable manufacturing processes.
June 25, 2026Drug Discovery News has released a new technology guide focused on optimizing and connecting molecular biology workflows to enhance research efficiency. The guide addresses critical stages of the research cycle, including molecular design, cloning, and high-throughput operations. For the synthetic biology sector, these advancements are essential for scaling production and improving data management across collaborative research environments.
June 25, 2026